Top 50 Medical Device Angel Investors (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Christina Jenkins
Angel
|
6 | United States, Canada | Series A, Seed, Series B | Health Care, Medical Device, Personal Health | |
|
Jason Calacanis
Angel
|
5 | United States, Australia, Canada | Pre-Seed, Seed, Series A | Software, Internet, E-Commerce | $100k–$13M |
|
bumpkins profile
Angel
|
4 | United States, Canada, India | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Software | $325k–$14M |
|
Jaffray Woodriff
Angel
|
4 | United States | Seed, Series A, Angel | Software, Biotechnology, Health Care | $640k–$11M |
|
sherwin matian
Angel
|
4 | United States | Pre-Seed | Software, Wearables, Health Care | |
|
Fred Moll, M.D
Angel
|
4 | United States, United Kingdom, The Netherlands | Seed, Series A, Angel | Medical Device, Health Care, Medical | |
|
Kevin Moore
Angel
|
4 | United States, India, Canada | Seed, Pre-Seed, Angel | Software, Health Care, E-Commerce | $120k–$3M |
|
Josh Hannah
Angel
|
4 | United States, Singapore, United Kingdom | Series A, Seed, Series B | Software, Internet, Information Technology | $2M–$80M |
|
Farzad (Zod) Nazem
Angel
|
4 | United States, Canada | Seed, Series A, Series B | Health Care, Analytics, Machine Learning | $650k–$31M |
|
Pierre Rigaux
Angel
|
4 | Belgium | Seed, Pre-Seed, Convertible Note | Sports, Medical Device | $563k–$1.1M |
|
Jennifer Fried
Angel
|
4 | United States | Seed, Series A, Series B | Health Care, Medical Device, Medical | |
|
Frank A. Bonsal
Angel
|
4 | United States, Canada | Series A, Seed, Series B | Education, Software, Health Care | $2.3M–$10M |
|
Zohar Gilon
Angel
|
3 | Israel, United States | Seed, Series A, Series B | Software, Internet, Medical Device | $1.5M–$15M |
|
Marc Benioff
Angel
|
3 | United States, United Kingdom, The Netherlands | Series A, Seed, Series B | Software, Health Care, SaaS | $850k–$40M |
|
Jessica Livingston
Angel
|
3 | United States, Mexico | Seed, Angel, Series A | Medical Device, Education, Health Care | |
|
Jeff Hammerbacher
Angel
|
3 | United States | Seed, Series A, Angel | Software, Artificial Intelligence, Biotechnology | $1M–$20M |
|
Vishal Rao
Angel
|
3 | United States, India, Canada | Seed, Pre-Seed | Software, Artificial Intelligence, Information Technology | $22k–$4M |
|
Schnidar Harald
Angel
|
3 | Austria | Seed, Angel, Pre-Seed | mHealth, Software, Biopharma | |
|
Paul Buchheit
Angel
|
3 | United States, Canada, India | Seed, Series A, Angel | Software, Health Care, E-Commerce | $100k–$8.5M |
|
Maurice Ferre, M.D.
Angel
|
3 | United States, United Kingdom | Series A, Seed, Angel | Medical Device, Medical, Health Care | |
|
Jacky Chen
Angel
|
3 | Canada, United States, China | Seed, Pre-Seed | Software, Health Care, Information Technology | $687k–$3.1M |
|
Paul Heydon
Angel
|
3 | United States, United Kingdom, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Mobile Apps | $600k–$12M |
|
Simanta Das
Angel
|
3 | Greece, United Kingdom, The Netherlands | Seed, Angel, Pre-Seed | Health Care, Apps, Education | |
|
Ray Muzyka
Angel
|
3 | Canada, United States | Seed, Pre-Seed | Health Care, Software, Information Technology | $91k–$1.9M |
|
Sophia Bendz
Angel
|
3 | Sweden, United Kingdom, United States | Seed, Pre-Seed | Health Care, Software, Apps | $1.1M–$3.6M |
|
Scott Belsky
Angel
|
3 | United States, Germany, United Kingdom | Seed, Series A, Series B | Software, Internet, SaaS | $1.2M–$31M |
|
Never WorkedHere
Angel
|
2 | United States | Seed, Series A, Series B | Health Care, Biotechnology, Medical Device | |
|
Dov Moran
Angel
|
2 | Israel, United States | Series A, Seed, Series B | Semiconductor, Hardware, Health Care | $1.2M–$74M |
|
Anne Wojcicki
Angel
|
2 | United States, United Kingdom, Canada | Seed, Series A, Series B | Health Care, Medical, Biotechnology | $765k–$20M |
|
Edward Ludwig
Angel
|
2 | Switzerland, United States | Seed, Series A, Corporate Round | Medical, Health Care, Medical Device | |
|
Eduardo Ronzano
Angel
|
2 | France, United States, United Kingdom | Seed, Pre-Seed, Angel | Software, SaaS, E-Commerce | $150k–$4M |
|
Luca Trevisan
Angel
|
2 | Italy | Series A | Medical, Health Care, Medical Device | $750k–$1.3M |
|
Carlos Gallardo
Angel
|
2 | Spain, United Kingdom | Seed, Series A | Health Care, Medical Device, Medical | |
|
Erhan Bilici
Angel
|
2 | United States, China, India | Seed, Equity Crowdfunding, Pre-Seed | Financial Services, FinTech, E-Commerce | $1k–$3.3M |
|
Michael Fainshtein
Angel
|
2 | United States | Seed | Sensor, Robotics, Software | $700k–$1.3M |
|
Juan Knuth
Angel
|
2 | Spain | Seed, Series A | Health Care, Biotechnology, Digital Media | |
|
Cyan Banister
Angel
|
2 | United States, United Kingdom | Seed, Series A, Angel | Software, Internet, Social Media | $500k–$11M |
|
Noel Hall
Angel
|
2 | Canada, United States | Seed, Angel | Biotechnology, Genetics, Life Science | |
|
Ted Leonsis
Angel
|
2 | United States, United Kingdom | Series B, Series C | Sports, Internet, Social Media | $8M–$26M |
|
David Pyott
Angel
|
2 | United States, The Netherlands | Series A, Series B | Medical, Biotechnology, Medical Device | $1.4M–$40M |
|
Laura Iris Ferro
Angel
|
2 | Italy | Pre-Seed | Health Care, Biotechnology, Medical Device | |
|
Ali Omar
Angel
|
2 | Finland, United States, Estonia | Seed, Pre-Seed, Angel | Software, SaaS, Artificial Intelligence | $54k–$2.1M |
|
Hampus Jakobsson
Angel
|
2 | Sweden, Denmark, United States | Seed, Angel, Pre-Seed | Health Care, Software, Artificial Intelligence | $92k–$2.1M |
|
Scott H. Cohen
Angel
|
2 | United States | Series A, Seed | Biotechnology, Manufacturing, Medical Device | $10M–$10M |
|
Paul Geyer
Angel
|
2 | Canada, United States | Seed, Series A | Health Care, Fitness, Medical Device | $1.1M–$6M |
|
Tom Williams
Angel
|
2 | United States, Canada, India | Seed, Series A, Series B | Software, Health Care, Financial Services | $1.3M–$67M |
|
Paul Graham
Angel
|
2 | United States, Egypt, United Arab Emirates | Seed, Series A, Angel | Software, E-Commerce, Enterprise Software | $1M–$12M |
|
Mark Bamforth
Angel
|
2 | United Kingdom, United States | Series A, Series B | Medical, Health Care, Biotechnology | $9.2M–$19M |
|
Michael Cope
Angel
|
2 | United States | Seed, Angel, Pre-Seed | Health Care, Apps, mHealth | |
|
Chip Hance
Angel
|
2 | Ireland | Series A | Medical, Health Care, Medical Device | |
| Access all 671 angel investors in Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Dr. Christina Jenkins is a Venture Partner at Phoenix Venture Partners.
Show more...Investment focus
- Industry: Health Care, Medical Device, Personal Health
- Stage:Series A, Seed, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 19
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Aria CV — Learn about Aria CV's novel implantable medical device designed to treat pulmonary hypertension (PH). Our elegant device has no battery, pump, or electronics.
- Madorra — Madorra Their goal is empowering women to live fuller, healthier lives. Madorra is working towards changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. They are focused on giving post-menopausal women and breast cancer survivors the power tochoose the non-hormonal treatment option they want.
- Siren Care — Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Siren significantly improves patient outcomes and experience by augmenting traditional healthcare with tech-enabled clinical models to provide whole person care. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive servicepowered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers.
Jason Calacanis is the Founder and CEO of Inside.com and Launch. He previously worked at Weblogs as a Co-Founder and CEO.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Australia, Canada
Investor stats
- Total investments: 333
- Round size: Seed $722k–$4M; Pre-Seed $100k–$1.9M; Series A $2.7M–$13M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- micro1 — We help companies hire and manage the best software engineers easily.
- Bonjuur — Housekeeping Membership that tidies up your house daily and cleans room by room, for a serene life. Welcome to Bonjuur Life.
- CyberFilm — Bring your story to life!
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 49
- Round size: Seed $2.9M–$9.1M; Pre-Seed $325k–$2M; Series A $10M–$14M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
- Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Angel Investor located in Charlottesville, VA
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Angel
- Geography: United States
Investor stats
- Total investments: 43
- Round size: Seed $640k–$4.3M; Angel $810k–$2.6M; Series A $3.4M–$11M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
- Fringe — With 100+ vendors, Fringe offers an employee lifestyle benefits experience that builds loyalty, productivity, and well-being. Learn more to get started!
- Starchive — Built by creators for creators, to maximize the control and ownership of their media, community, and commerce in the Visual Economy.
sherwin matian
Show more...Investment focus
- Industry: Software, Wearables, Health Care
- Stage:Pre-Seed
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Dentulu — Dentulu lists most of the best online dental consultations in the USA. Book appointments 24/7 and connect with a dentist in less than 15 minutes.
Frederic H. Moll, M.D. serves as Chief Development Officer of Johnson & Johnson’s Digital Surgery Group. Prior to Johnson & Johnson, Dr. Moll was CEO of Auris Health, Inc., located in Redwood City, California. Prior to Auris, Dr. Moll founded Hansen Medical and served as the company’s first CEO, and in 1995, founded Intuitive Surgical,Inc. (Nasdaq: ISRG).Dr. Moll earned a M.D. from the University of Washington, School of Medicine, a M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Seed, Series A, Angel
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 14
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Mendaera — Mendaera enables all healthcare providers to perform precise and consistent point-of-care interventions. Their platform combines real-time imaging, robotics, and artificial intelligence to aid physicians in image acquisition and interpretation.
- Bright Uro — Actionable Insight Improves Outcomes
- Proclaim — Proclaim is a revolutionary, at-home, custom-jet oral irrigator that provides patients with the easiest, fastest, most effective at-home oral care.
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, India, Canada
Investor stats
- Total investments: 97
- Round size: Seed $120k–$3M; Pre-Seed $120k–$2.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
- Augmend — AI-augmented knowledge transfer across developers through a platform that captures and shares expertise.
Josh Hannah is a general partner with Matrix Partners. His entrepreneurial career began in 1999 when he cofounded Flutter.com in London and later led a merger with his biggest competitor, Betfair.com. The combined entity revolutionized the gaming industry by building the world’s first online marketplace for sports betting. Josh returned to theStates in 2004. Soon after, he and a partner purchased eHow, an ailing, Web 1.0, how-to directory. Josh and his partner outsourced content creation to the community and employed then-new advertising and search engine optimization techniques. They increased revenue and traffic 30-fold before selling the company to Demand Media in 2006 for a 400-X return. As a partner at Matrix, Josh has invested in Huddle, Inflection and Taulia. Prior to joining Matrix, Josh invested in successful startups such as Aardvark (acquired by Google), Blingo (acquired by Publishers Clearing House), Designer Apparel (acquired by Sugar Media), Friendster (acquired by MOL Global), Minted, uShip and Wetpaint.
Show more...Investment focus
- Industry: Software, Internet, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United States, Singapore, United Kingdom
Investor stats
- Total investments: 55
- Round size: Seed $2.2M–$4.2M; Series A $2M–$33M; Series B $5.5M–$80M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- ClayStack — Multichain liquid staking platform that allows users to stake their assets, mint staking derivatives, and participate in DeFi.
- Ondo Finance — Institutional Grade Finance. On-Chain. For Everyone.
- Meson Network — meson network provides fast,stable,cheap content delivery globally
Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.
Show more...Investment focus
- Industry: Health Care, Analytics, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 36
- Round size: Seed $650k–$11M; Series A $4.2M–$31M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
- Ceevra, Inc. — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
- TigerGraph — TigerGraph is the fastest and only scalable graph database for the enterprise. Unleash the power and speed of our graph analytics platform today.
Pierre Rigaux
Show more...Investment focus
- Industry: Sports, Medical Device
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Belgium
Investor stats
- Total investments: 4
- Round size: Seed $563k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jennifer Fried is the CEO & Co-Founder of ExplORer Surgical .
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 11
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Madorra — Madorra Their goal is empowering women to live fuller, healthier lives. Madorra is working towards changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. They are focused on giving post-menopausal women and breast cancer survivors the power tochoose the non-hormonal treatment option they want.
- Nest Collaborative — Nest Collaborative offers online lactation consults. Virtual appointments are available same-day & are covered in full by most insurance plans.
- Solace Therapeutics — Solace Therapeutics is a medical device company that develops and commercializes non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS). It is dedicated to improving the patient’s quality of life byeliminating side effects typically associated with current drug and surgical therapies.The company offers a technology that is designed to offer patients an office-based therapy that does not require anesthesia or surgery, no lifestyle change required, before or after treatment, and reversible at any time.
Mr. Bonsal has been an active advisor to Outcome Capital since its inception in 1998. Mr. Bonsal is a Co-Founder and General Partner at New Enterprise Associates, one of the country’s largest venture capital firms. NEA invests in early-stage companies and works with management to nurture and build companies of real and lasting value. His investmentactivities focus on a broad range of technical and service-oriented companies. Mr. Bonsal is a member of the Board of Trustees of the Johns Hopkins Hospital and a member of the Johns Hopkins Hospital Endowment Board. Also, Mr. Bonsal serves on the Boards of Directors of Ceratech, CIBERNET Corporation, and COVEGA Corporation, as well as an investment advisory firm, Brown Investment Advisory and Trust Co. Before co-founding NEA, Mr. Bonsal was a general partner of Alex. Brown & Sons.
Show more...Investment focus
- Industry: Education, Software, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 25
- Round size: Series A $2.3M–$10M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- ZeroFox — ZeroFox provides enterprises protection, intelligence and disruption to identify and dismantle external threats in one comprehensive platform.
- Adlumin — Adlumin's Security Operations Platform sheds light on advanced cyber threats, system vulnerabilities, and sprawling IT operations.
- Cohero Health — Cohero Health transforms respiratory disease management for the digital age. Track your asthma or COPD and get medication alerts with the BreatheSmart mobile app.
Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.
Show more...Investment focus
- Industry: Software, Internet, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 32
- Round size: Seed $1.5M–$9.3M; Series A $1.6M–$11M; Series B $4.5M–$15M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- CADY — CADY's mission is to fully automate the inspection and verification of Printed Circuit Board (PCB) schematics, using AI technology.
- Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
- Everafter.ai — Build personalized hubs for every customer - from POC and onboarding plans to success plan and monthly communications. And the best part - embed it inside your product.
Marc Benioff is Chair and Chief Executive Officer of Salesforce. Marc Benioff attended the University of Southern California.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 108
- Round size: Seed $850k–$11M; Series A $3M–$25M; Series B $3M–$40M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Warp — Warp is a Rust-based terminal reimagined to focus on productivity, efficiency, and speed. It is now available on MacOS. Warp has an IDE-like input area and it groups input and output together into atomic units. It also features Warp AI, which explains errors and suggests commands using AI.
- ArteraAI — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
- HiNOTE — Hinote is a unique, expressive method of mobile communication for people who enjoy flexing, staying still, and delighting.
Jessica Livingston is a founding partner at Y Combinator. She is also the organizer of Startup School, the big annual startup conference, and the author of Founders at Work, a collection of interviews with successful startup founders.Y Combinator was the first of the new startup “incubators” that fund a bunch of startups at once. Since 2005 YChas funded over 560 companies, including Dropbox, Airbnb, Stripe, and Reddit.
Show more...Investment focus
- Industry: Medical Device, Education, Health Care
- Stage:Seed, Angel, Series A
- Geography: United States, Mexico
Investor stats
- Total investments: 15
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Balto — Balto, the sports gaming platform made for the casual, everyday fan. We’re thrilled to have you. As a quick intro, we’re Nick Montana, Spencer Cassidy and Joel Karacozoff, three individuals with a passion for gaming and an affinity for bringing people together. As driven co-founders to deliver the best experience, They have set out to create asimple, social and fun gaming interface for all.
- Elpha — Elpha is where women succeed at work together. Become a member to access daily conversations with experts, insider job opportunities, and a lot of women talking candidly about work and life. Plus membership is free!
- Hype and Vice — Hype and Vice combines on-trend fashion with University brands to create officially licensed college apparel women! Cool college apparel to wear for tailgates and gamedays or to lounge around your dorm.
Jeff Hammerbacher - Partner & Co-Founder @ Techammer
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: United States
Investor stats
- Total investments: 25
- Round size: Seed $1M–$20M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Vectara — Put Generative AI into action with Vectara's end-to-end LLM pipeline, Grounded Generation, & APIs (Vectors, Hybrid Search, Summarization)
- Lambda — GPU Workstations, GPU Servers, GPU Laptops, and GPU Cloud for Deep Learning & AI. RTX 3090, RTX 3080, RTX A4000, RTX A5000, RTX A6000, and A100 Options. Ubuntu, TensorFlow, and PyTorch Pre-Installed.
- Together — Together will enable researchers, developers & companies to leverage and improve artificial intelligence with an intuitive data, models & computation platform.
Advisory CTO and Angel Investor
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed
- Geography: United States, India, Canada
Investor stats
- Total investments: 66
- Round size: Seed $220k–$4M; Pre-Seed $22k–$3M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Berri AI — A website made with Typedream.
- Anarchy — Anarchy builds a cloud platform for AI pioneers to build LLM tools augmented with external interactivity.
- Consensus — Consensus uses AI to extract and summarize scientific insights from peer-reviewed sources. For any question, what's the Consensus?
Entrepreneur, Angel Investor, Scientist and Inventor
Show more...Investment focus
- Industry: mHealth, Software, Biopharma
- Stage:Seed, Angel, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 7
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A, Angel
- Geography: United States, Canada, India
Investor stats
- Total investments: 103
- Round size: Seed $1M–$5M; Angel $100k–$1M; Series A $650k–$8.5M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
- Character.ai — character.ai is bringing to life the science-fiction dream of open-ended conversations and collaborations with computers.
- Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Dr. Maurice R. Ferré was the founding President and Chief Executive Officer of MAKO Surgical Corp, serving from 2004 until the acquisition of the company by Stryker Corp. for $1.7 billion in 2014.In June 2007, Dr. Ferré received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, he foundedVisualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until 2002 when the company was acquired by GE Healthcare, the healthcare division of the General Electric Company. Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare, until 2004.Dr. Ferré holds an M.D. and a Master’s degree in Public Health from Boston University.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series A, Seed, Angel
- Geography: United States, United Kingdom
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Heru — Discover the future of vision care and virtual eye exams with Heru. Click to learn about our AR eye machines and virtual visual field exams.
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
- DermaSensor — We've built a handheld, objective device to assist primary care providers in evaluating skin lesions for the risk of cancer in seconds. Early detection saves lives.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jacky is dedicated to angel investment and has built up a portfolio of more than thirty startup companies in Canada and the US. His target investments are the early-stage B2B companies with disruptive technologies and business potential in enterprise software, information technologies, MedTech, and Advanced Manufacturing.Jacky has acquiredconcrete business experiences as a successful founder in the startup ecosystem and an executive of Fortune 500 companies over two decades. His remarkable accomplishments range from building startups from scratch to leading a billion-dollar business with the leverage of 14,000 enterprise channel partners. The unique journey has shaped Jacky's outstanding of investing in early startups.Jacky holds the degrees of Mater's E.E. and MBA, and he graduated from CEIBS and The Wharton Business School of the University of Pennsylvania.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Canada, United States, China
Investor stats
- Total investments: 20
- Round size: Seed $687k–$3.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Workwolf — Workwolf is a Toronto-based start-up with a management team who has led 7 start-ups, had 2 successful exits, and has taken a company public with a $1.8B IPO. Workwolf CEO Erik Simins is an SME in HR who previously founded MAGNUS HRS, a staffing company now servicing over 150 enterprise customers. The technology at Workwolf solves two of the biggestpain points in employment: applicant filtration and verification, and does so by empowering users to identify better candidates faster. Winner of global awards in both 2020 and 2021 for innovation and market potential, Workwolf is ramping up for its multi-national roll-out with ManpowerGroup in September that will coincide with a $4.5M Seed financing round.
- Agile Devices — Agile Devices offer catheter-based interventional procedures helping patients during a stroke. It helps medical practitioners reduce the procedure time to respond to time bound emergencies.
- Traction Technology Partners — Traction is a powerful SaaS collaboration platform for evaluating, adopting and managing new technologies across the enterprise. The platform includes Project Management and CRM tools designed specifically for enterprise teams tasked with discovering and evaluating new technologies. Traction is used by IT, Innovation and Corp Dev teams toaccelerate their digital transformation projects, and to speed up the way they find, manage, and adopt new technologies. Traction also offers On-Demand Research services delivered through its platform.
30 years as a founder, operator, investor, and advisor. Previously Paul was a Co-Founder and General Partner at LVP. Paul has invested in Supercell (majority acquired by Tencent), Unity (NYSE:U), Matchmade, Radiant Entertainment (acquired by Riot Games), Boomlagoon (acquired by Wargaming), Peak (acquired by Hachette Livre), AppOnboard, FRVR,Starform, Gameclub, Coherence, Lucid Sight, Doppio Games, Capture, Flick, EvenPrime, Tellie & Litho and others. Previously, he was an investment banker at Avista Partners, Commerzbank Securities & ING Barings. He has both a HBA & MBA from the Richard Ivey School of Business at University of Western Ontario in Canada.
Show more...Investment focus
- Industry: Software, Gaming, Mobile Apps
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Finland
Investor stats
- Total investments: 51
- Round size: Seed $1M–$4.5M; Pre-Seed $600k–$660k; Series A $3.7M–$12M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Tellie — Create a free website/link-in-bio to market your art, release new music, increase your followers, sell merchandise, and share your portfolio/resume/EPK. Token Gate all.
- Coherence — Unlock your multiplayer possibilities
- Glean AI — Glean AI is the only Accounts Payable solution that combines smart automation with spend intelligence and powers Finance teams to drive material savings.
Simanta Das is a Managing Partner at Stalhmarg and Founder of Rising Stars Ventures.
Show more...Investment focus
- Industry: Health Care, Apps, Education
- Stage:Seed, Angel, Pre-Seed
- Geography: Greece, United Kingdom, The Netherlands
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- RTsafe — RTsafe provides personalized care in radiation oncology by combining proven expertise in medical physics and highly accurate 3D printing technology. Through its innovative products which include remote dosimetry services and 3D printed dosimetry phantoms, built from real patient anatomical data, supports radiotherapy professionals and significantly enhances patient safety.
- Fika — Fika provides guided soft skills micro-training that integrates easily into your work calendars and existing meetings. Book your free Fika trial.
- NeuroReality — NeuroReality is developing Koji’s Quest, a unique VR-based SAAS solution that puts the patient at the center of the rehabilitation experience & connects all key stakeholders by providing patients with better health outcomes, allowing clinicians to deliver superior care to more patients without increasing care costs, & permits insurancecompanies to save money while improving care standards. NeuroReality registered 19-12-2017 and is working with a team of 12 devoted developers, neuroscience researchers, creatives and business developers.
Originally trained as a medical doctor, Dr. Ray Muzyka cofounded BioWare, a video game development studio focusing on story and character, in the early 1990s. He practiced emergency/family medicine for two years full time, with medicine transitioning to part-time over the following decade as he focused on his role as BioWare’s CEO. BioWare wasacquired by Electronic Arts in 2007, and Dr. Muzyka took on the roles of Senior Vice President at Electronic Arts and General Manager of EA’s BioWare division, which grew over the next five years to span eight development locations worldwide with about 2000 staff (1400 full time). He retired from video games in October 2012, with his third “career chapter” at ThresholdImpact, where he focused on sustainable, profitable impact investing: mentoring and angel investing in information technology, new media, and medical innovations with social entrepreneurs. An active angel investor and entrepreneurial mentor, Dr. Muzyka is a member of the Young Presidents’ Organization, the A100, the Ashoka Support Network, and the Board of Governors of the University of Alberta (serving as Chair of the Human Resources Committee and on the Learning and Discovery Committee and as a member of the University of Alberta Advancement Council). He is Chair of the University of Alberta’s entrepreneur Venture Mentoring Service, a venture advisor at iNovia Venture Capital, and a member of the Alberta Research and Innovation Advisory Committee and the Alberta Premier’s Advisory Committee on the Economy. He also serves on a number of private company boards. He previously served on the board of the Academy of Interactive Arts and Sciences from 2001-2008 and was on the Board of Trustees of the Stollery Children’s Health Foundation from 2012-2015. He was inducted into the Academy of Interactive Arts and Sciences’ Hall of Fame in 2011 and received the International Game Developers’ Choice Awards 2013 Lifetime Achievement Award. Dr. Muzyka received the inaugural Alumni Innovation Award in 2015 from the University of Alberta. He additionally was named as the 2017 Allard Chair in Business at the MacEwan University’s School of Business and as an Honorary Paul Harris Fellow by Rotary Club International in 2016, in recognition for his philanthropic efforts. Other awards include entry into Canada’s Top 40 under 40 and Ernst and Young’s 2001 Entrepreneur of the Year (IT, Prairies).He obtained his Bachelor of Medical Science from the University of Alberta in 1990, his Doctorate of Medicine from there in 1992, and his MBA from the University of Western Ontario (Ivey School of Business) in 2001.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 23
- Round size: Seed $91k–$1.6M; Pre-Seed $320k–$1.9M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.
- Modality.AI, Inc. — Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health.
- Gray Oncology Solutions — Gray Oncology Solution is a healthcare enterprise software company that commercializes GrayOS, the operating system for oncology.
Sophia Bendz - Partner @ Cherry Ventures
Show more...Investment focus
- Industry: Health Care, Software, Apps
- Stage:Seed, Pre-Seed
- Geography: Sweden, United Kingdom, United States
Investor stats
- Total investments: 39
- Round size: Seed $1.1M–$3.6M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- mayk — Mayk sounds. Mayk music. Mayk noise. Mayk it... In an app.
- Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
- Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.
Scott Belsky joined Adobe as Chief Product Officer, Executive Vice President - Creative Cloud in 2017.Scott Belsky is an entrepreneur, author, and investor. Scott co-founded Behance in 2006, and served as CEO until Adobe acquired Behance in 2012. Millions of people use Behance to display their portfolios, as well as track and find top talent acrossthe creative industries. After Behance's acquisition, Scott served as Adobe's Vice President of Products, rebooting Adobe's mobile product strategy and leading Behance until 2016 when he became a full-time venture capitalist as a General Partner at Benchmark. Scott returned to his love for the creative world, and building products and teams full-time, as Chief Product Officer and EVP of Creative Cloud, at Adobe in late 2017. He continues to work with Benchmark as a Venture Partner, as well as several other early stage venture firms. Scott also manages a portfolio of over 150 private companies from his early investments and product advisory roles in companies including Pinterest, Uber, Carta, Flexport, Airtable, sweetgreen, and many others in the early stages.Scott is also the author of the bestselling books Making Ideas Happen and The Messy Middle (Portfolio Imprint, Penguin Books, April, 2010 and Oct 2018, respectively).Scott is also the founder of the 99U conference for leaders in the design world, and is an advocate for technology and community initiatives that empower creative people and help businesses leverage the creative potential of their people. In 2010, Scott was also included in Fast Company's list of "100 Most Creative People in Business."Prior to founding Behance, Scott helped grow the Pine Street Leadership Development Initiative at Goldman, Sachs & Co. Scott was especially focused on organizational improvement and strengthening relationships with clients. Scott serves on the Advisory Board of Cornell University's Entrepreneurship Program and is a member of the Board of Trustees for the Smithsonian Cooper-Hewitt National Design Museum. He attended Cornell University as an undergraduate and received his MBA from Harvard Business School. Scott and his family live in New York City and San Francisco.
Show more...Investment focus
- Industry: Software, Internet, SaaS
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 168
- Round size: Seed $1.2M–$6.7M; Series A $5M–$15M; Series B $16M–$31M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Grit — Grit automatically fixes technical debt by combining static analysis and machine learning to generate pull requests that clean up code and migrate to the latest frameworks.
- LLM Shield — Powerful leak protection from LLMs like ChatGPT, Bard, Bing, or Claude. Deploy protection today.
- Infringements — Monitor your patents and get instant alerts on potential infringements.
Michael Berman is a successful entrepreneur within the medical device industry.He joined Scimed in 1986, leading its marketing activities until its merger with Boston Scientific in 1995.From 1995-2000 he served as President of Boston Scientific/Scimed where he provided leadership and management for more than 4000 employees in fourlocations, and in 1997 he was named a member of Boston Scientific’s Executive Committee.Since leaving Boston Scientific, Mr. Berman co-founded or was a founding director of seven medical technology companies, a number of which have been acquired by leading strategic medical device companies.He currently serves on the board of eight medical industry companies; Aetherworks, Apnex, Benechill, Cardiosonic, PharmaCentra, MikrobEX, AngioSlide and InterValve.Mr. Berman received both his BS and MBA at Cornell University and was inducted into the Minnesota Business Hall of Fame in 2010.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Apnex Medical — Apnex Medical, Inc. manufactures and markets medical devices such as implants for the treatment of obstructive sleep apnea. Apnex Medical, Inc. was incorporated in 2006 and is based in Saint Paul, Minnesota.
- Prospex Medical — Prospex Medical, now dormant, was a medical device incubator focused on innovating and incubating novel medical technologies. With an emphasis on regulated medical devices and non-regulated (quasi-consumer) medical products, Prospex Medical explored a wide variety of opportunities in the health care market. Through a process of marketidentification, clinical and technical research, physician collaboration, intellectual property generation, and proof of concept, Prospex Medical successfully created and spun-out two companies: BridgePoint Medical (www.bridgepointmedical.com) and Apnex Medical (www.apnexmedical.com).
- BridgePoint Medical — BridgePoint Medical, a private company with headquarters in Minneapolis, Minnesota, is focused on developing innovative and proprietary technology in the field of interventional cardiology for access to and treatment of chronic total occlusions.
Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.
Show more...Investment focus
- Industry: Semiconductor, Hardware, Health Care
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 22
- Round size: Seed $3M–$4.5M; Series A $1.2M–$23M; Series B $25M–$74M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Rapid — RapidAPI is an API Hub that enables over 3 million developers to find, manage, and connect to APIs. RapidAPI lets developers manage all API integrations from one place and gives real-time performance metrics. RapidAPI was founded in 2014 and is headquartered in San Francisco, California.
- Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
- Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.
Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 51
- Round size: Seed $765k–$10M; Series A $7M–$20M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Calypso AI — CalypsoAI combines industry-leading AI testing and human-in-the-loop decision making to give you the confidence you need to push AI projects into production.
- Eureka Health — Helping people with chronic conditions mitigate their symptoms.
- Helium Health — Helium Health empowers healthcare providers in Africa with digital tools, financing solutions, and data partnerships. Learn more about our innovative solutions.
Edward Ludwig has been a Member of the Board of Directors of Boston Scientific since March 2014. Edward is the former Chairman of the Board of Directors of Becton, Dickinson and Company (“BDX”), a global medical technology company, having served in that position from February 2002 through June 2012. Edward also served as BDX’s ChiefExecutive Officer from January 2000 to September 2011 and as its President from May 1999 to December 2008. Edward joined BDX as a Senior Financial Analyst in 1979. Prior to joining BDX, Edward served as a Senior Auditor with Coopers and Lybrand (now PricewaterhouseCoopers) where he earned his CPA and as a financial and strategic analyst at Kidde, Inc. Edward serves as Lead Director on Aetna Inc.’s Board of Directors and chairs its Finance Committee and is a Member of the Board of Directors of Xylem, Inc. Edward serves as the Non-Executive Chairman of POCARED, a privately held firm in Israel. Edward is also a Member of the Board of The Center for Higher Ambition Leadership, which is dedicated to studying, documenting and advancing the principals of Higher Ambition Leadership that drive the most successful enterprises in terms of longer term shared value creation. Edward served as a Member of the Board of Trustees of the College of the Holy Cross (2005-2013), and the Columbia Business School Board of Overseers (2010-2015). Edward also served as a Member of the Board of Trustees of the Hackensack University Medical Center Network Board of Trustees. Edward received a B.A. degree in Economics and Accounting from The College of the Holy Cross and a MBA degree from Columbia University.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A, Corporate Round
- Geography: Switzerland, United States
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Spiden — SPIDEN - Products that enable real-time and continuous monitoring of blood biomarkers for treatment of critical and high-risk patients.
- Velano Vascular — Establishing a new standard of care for inpatient blood draws by improving the experience and reducing pain, risks and inefficiencies of existing practices.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Eduardo Ronzano is the Founder of KelDoc.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 82
- Round size: Seed $696k–$4M; Angel $643k–$2.5M; Pre-Seed $150k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Screeb — Make products your users will love by using Screeb, the all-in-one tool for Product Discovery. Product analytics, user recruitment, and more!
- Spades — Guests Scan a QR code to view the menu and Pay, they can also Split the amount and Tip the staff. Now faster than ever.
- Morpho Labs — Morpho is an on-chain peer-to-peer layer on top of lending pools. Rates are seamlessly improved for borrowers and lenders while preserving the same guarantees. Morpho combines the efficiency of P2P with the liquidity of lending pools. Users enjoy an improved APY while maintaining the pool’s flexibility
Luca Trevisan Sales Manager and Business Coordinator.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Series A $750k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
Carlos Gallardo
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Spain, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amelia Virtual Care — Amelia, formerly Psious VR, is a Virtual Reality software for use by mental health professionals in their therapy sessions with over 100 available virtual environments.
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Risk Management professional, experienced in Stress Testing and Capital Planning. Economist, Investment Analyst, Financial Consultant. Interested in FinTech.
Show more...Investment focus
- Industry: Financial Services, FinTech, E-Commerce
- Stage:Seed, Equity Crowdfunding, Pre-Seed
- Geography: United States, China, India
Investor stats
- Total investments: 44
- Round size: Seed $50k–$3.3M; Pre-Seed $205k–$500k; Equity Crowdfunding $1k–$723k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nada — Finance, Invest and Bank your real estate.
- DigiBuild — DigiBuild develops a construction management software that utilizes blockchain technology. It captures transactions from all of the different systems being utilized on the project and puts them into a filterable, searchable, and comparable project timeline to remove the waste and fraud for better data insights and decision making that will stopbudget overages.
- Upright — Meet Upright, the good for you go-to. Our first product is a category-defining high-protein, allergen-free Instant Oatmilk in three creamy, delicious flavors: original, vanilla, and chocolate. Each tasty cup of our oatmilk packs the same key nutrients as dairy, without the unwanted allergens or environmental impact.
Michael Fainshtein
Show more...Investment focus
- Industry: Sensor, Robotics, Software
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $700k–$1.3M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Mircod — Service for complex prototyping of IoT products and solutions.
Juan Knuth
Show more...Investment focus
- Industry: Health Care, Biotechnology, Digital Media
- Stage:Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Devicare — Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The company's medical devices are useful in measuring the level of biomarkers in body fluids such as saliva, tears, sweat, sputum, feces, urine or blood, enabling medical professionals to detect and treat various infectious diseases.
Cyan Banister is a partner at Founders Fund, where she invests across sectors and stages with a particular interest in augmented reality, fertility, heavily regulated industries and businesses that help people with basic skills find meaningful work. Prior to joining Founders Fund, Cyan was an active angel investor with a portfolio including Uber,Thumbtack, SpaceX, Postmates, EShares, Affirm and Niantic, creator of Pokémon GO. A self-taught engineer and entrepreneur, Cyan has held a number of technical leadership positions throughout her career. As an early employee at IronPort, which was acquired by Cisco, Cyan oversaw support infrastructure and performance for a global customer base. She has a passion for the arts and is a voracious film, documentary and media consumer.
Show more...Investment focus
- Industry: Software, Internet, Social Media
- Stage:Seed, Series A, Angel
- Geography: United States, United Kingdom
Investor stats
- Total investments: 130
- Round size: Seed $600k–$3M; Angel $500k–$600k; Series A $1M–$11M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- TipTop — Buying stuff is easy, selling it is hard. But maybe there is a world where you don't have to sell things any longer? Curious?
- Orson — Meaningful connection is a universal human need. It's our stories that create empathy and bind us together.
- Mother Science — Discover Mother Science, a revolutionary biotech skincare brand with a clinically proven serum for hyperpigmentation and sun damage.
Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Seed, Angel
- Geography: Canada, United States
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
- Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
Ted Leonsis is the Founder, Chairman, Principal Partner, and Chief Executive Officer of Monumental Sports and Entertainment and a Co-founder at Revolution Growth. He was a CEO at AOL and attended Georgetown University.
Show more...Investment focus
- Industry: Sports, Internet, Social Media
- Stage:Series B, Series C
- Geography: United States, United Kingdom
Investor stats
- Total investments: 44
- Round size: Series B $8M–$26M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- OxiWear — OxiWear ear-wearable devices for continuous oxygen monitoring and emergency alerting to detect and prevent silent-hypoxia caused by pulmonary hypertension, high altitude & high cardio activities, and COVID-19. Oxiwear's patented, a novel ear-worn pulse oximeter is intended for use in clinical and consumer settings.
- HumanFirst — HumanFirst enables better integration and analysis of digital health technologies in clinical trials.
- Kiswe — Kiswe is a video technology startup providing live media solutions to global sports and entertainment content owners. Our cloud streaming technology transforms the way live games and events are professionally produced and broadcasted.
Former Chairman and CEO of Allergan; Lead Director of Avery Dennison Corporation, member of the Supervisory Board of Royal Philips in the Netherlands, Vice Chairman of the Board of Trustees of Chapman University, member of the Governing Board of the London Business School, President of the International Council of Ophthalmology Foundation, memberof the Advisory Board of the Foundation of the American Academy of Ophthalmology, and member of BioMarin Pharmaceuticals Board of Directors.
Show more...Investment focus
- Industry: Medical, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: United States, The Netherlands
Investor stats
- Total investments: 4
- Round size: Series A $1.4M–$13M; Series B $6.4M–$40M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Bioniz Therapeutics — Acquisition includes two first-in-class clinical-stage assets and proprietary product discovery platform Creates a robust immunology pipeline with significant value-creating milestones, and provides a strong clinical and research team with complementary expertise in immuno-inflammatory diseases Closing consideration of 5,699,492 shares of common stock of Equillium E quillium to host a conference call and webcast today at 8:00 a.m. Eastern Time Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it has acquired Bioniz Therapeutics, Inc., a privately held clinical-stage biotechnology company. Bioniz developed its novel structured-domain peptides, including BNZ-1 and BNZ-2, entirely in-house from its proprietary product discovery platform. The Bioniz lead product candidates are multi-specific
- Mellon Medical — Mellon Medical provides suturing tools for surgeons to improve medical procedures. The company's goal is to help medical specialists improve patient outcomes by providing them with the best possible suturing tools. It commercializes surgical instruments to allow single-handed stitching, enabling efficient and effective suturing of tubular andlayered structures.Mellon Medical was established in 2013 and is headquartered in Nijmegen, Gelderland.
- Sienna Biopharmaceuticals — informasi Pola Slot Online Gacor Hari ini 2023
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Laura Iris Ferro
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
Ali Omar is a Member of the Finnish Business Angels Network. He attended Aalto University and the University of Oulu.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Angel
- Geography: Finland, United States, Estonia
Investor stats
- Total investments: 59
- Round size: Seed $215k–$2.1M; Angel $54k–$1.6M; Pre-Seed $54k–$707k
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- MÖ Foods — MÖ Kaurajogu is domestic, completely herbal and above all delicious. All our products are manufactured in Central Ostrobothnia, Lohtaja.
- GoalProfit — Optimize operations, drive revenue, and delight consumers with native AI and automation. Harness the power of Digital Wave Technology!
- Builderhead — Builderhead is a construction management software designed for real estate developers and general contractors. The software combines project development, procurement, and construction management into a streamlined pipeline. We bring an industry spesific Project Development CRM, Bid Management Tools and Project Management Software in one easy-to-useplatform which integrates easily with other most used software in the industry. Even thought the construction industry accounts for 13% of the world’s GDP, there's been a global problem of poor productivity within the industry as productivity growth has increased only 1% over the past 20 years. From the real estate developers and general contractors point of view, the biggest issue is the projects that turn unprofitable unexpectedly. One unprofitable project destroys the whole year profits and another one can bankrupt the entire company. Most of the decisions that affect the success of a project are made before construction begins, but still there are no smart tools available for that stage to help the construction companies avoid unprofitable projects. We solve this global problem by bringing the most critical steps to the success of a construction project on the same platform.
Hampus Jakobsson is a General Partner at early stage climate tech venture fund Pale Blue Dot.Prior to co-founding Pale Blue Dot, Hampus was a Venture Partner at science fund Blue Yard and a prolific angel investor with >100 angel investments. He co-founded of The Astonishing Tribe (acquired by Blackberry in 2010 for $150m). He left Blackberry2012 to found Brisk.io a sales productivity tool which folded 2016.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Angel, Pre-Seed
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 37
- Round size: Seed $155k–$2.1M; Angel $92k–$1.2M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
- Mojo — Laboratory-grade AI-powered semen test at home. Test your sperm count, motility, volume and concentration with the Mojo kit. Check your fertility from home at low cost.
- Volta Greentech — Battling global warming by reducing methane emissions from cows
Scott H. Cohen is the President, Founding Partner of Crown Predator Holdings. He attended Tufts University.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Medical Device
- Stage:Series A, Seed
- Geography: United States
Investor stats
- Total investments: 9
- Round size: Series A $10M–$10M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Treez — Treez is a leading enterprise cloud platform that streamlines retail supply chain operations within the cannabis market.
- Establishment Labs — Establishment Labs is a medical technology company with a strong emphasis on innovation that designs, develops, manufactures and markets an innovative product portfolio. Its CE-marked Motiva Implants® line of silicone breast implants (http://www.motivaimplants.com) utilizes ultra-high purity medical-grade silicone and is subject to thestrictest quality assurance testing throughout the manufacturing process. Motiva Implants are sold in more than 60 countries worldwide. Puregraft®’s FDA cleared and CE-Marked technology provides plastic surgeons with purified fat for reinjection on the sterile field and is used in hospitals and clinics around the world. Divina® is a proprietary 3D imaging technology for full integration in consultation and surgical planning of unique solutions for breast aesthetics and reconstruction. All manufacturing facilities are fully compliant with both FDA and ISO applicable standards.
- WindMIL Therapeutics — WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients. The company leveraging its proprietary platform to develop a novel class of cell therapies called MILs (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow. WindMIL Therapeutics wasestablished in 2015 and is based in Baltimore, MD.
Paul Geyer, a successful Medtech Entrepreneur and experienced Board member. Over the past 20 years Paul founded and led two companies through their growth phase, in one case to a successful private exit and in the other case through growth as a public company with numerous acquisitions. Both companies have grown to be anchor medical devicecompanies in the Vancouver area, employing more than 350 people.In 1991 he founded Mitroflow International Inc., a tissue heart valve company. Paul grew the company from 9 employees to more than 125 employees in 1999. In 1999 Paul sold Mitroflow to Sulzer Medica, for more than $50 mil. Paul's leadership resulted in Mitroflow growing to more than 200 employees, making it one of the largest medical devices companies in the Vancouver area. In 2001 Paul started Medical Ventures, a new specialty vascular device company where he is currently Chairman of the Board. From its inception to June 2008, Geyer held the position of CEO at Medical Ventures (now Neovasc) and was responsible for raising over $40 million in Equity financing and growing the company’s product portfolio through internal development and the acquisition of 3 other companies. In 2008 Paul began focusing on sharing is expertise to assist other Entrepreneurs to build successful businesses, through his involvement as a mentor or Board member. He also focused on building the local community through his involvement as a Board member of BC technology industry association, along with a number of non-profit community based organizations. Paul is actively engaged as a Philanthropist, as Chairman of the Board of Social Venture Partners Vancouver, involved with Science World, Entrepreneurship at UBC, Project Somos Children’s Village and other organizations.Paul is currently the CEO of LightIntegra Technology Inc., a spin-off from Canadian Blood Services which has developed the ThromboLux technology, used to determine platelet quality for blood transfusions.
Show more...Investment focus
- Industry: Health Care, Fitness, Medical Device
- Stage:Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 8
- Round size: Seed $1.1M–$6M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Stoko design — Get the same level of joint support as a rigid knee brace in the form of a compression tight. Covered by insurance. Fast & free shipping. Hassle-free returns. Backed by orthopedic surgeons. Recommended by Olympians.
- Arbutus Medical — Arbutus Medical manufactures medical devices that simplifies orthopedic surgery and reduce the cost of healthcare to help treat patients worldwide.
- HeadCheck Health — HEADCHECK HEALTH simplifies the process of executing and monitoring concussion protocols. Learn more!
Tom Williams
Show more...Investment focus
- Industry: Software, Health Care, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, India
Investor stats
- Total investments: 74
- Round size: Seed $1.3M–$5M; Series A $5.1M–$12M; Series B $10M–$67M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Unito — Connect the tools you're already using with deep 2-way integrations and optimize workflows for Asana, Jira, Trello, Google Sheets and more.
- Delphia — Invest with your data, not your money.
- NorthOne — NorthOne is an online Business Account with built-in features to make business banking fast and easy. No overdraft fees. No minimum balance. No hidden fees.
Paul Graham
Show more...Investment focus
- Industry: Software, E-Commerce, Enterprise Software
- Stage:Seed, Series A, Angel
- Geography: United States, Egypt, United Arab Emirates
Investor stats
- Total investments: 39
- Round size: Seed $1M–$5.8M; Series A $3.5M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Novig — Novig is a peer-to-peer sports betting exchange and the first platform to offer commission-free bets.
- Manara — We identify and thoroughly vet undiscovered talent. You hire them directly for onsite or remote jobs, diversifying and accelerating your team. Our mission is to accelerate the growth of the Arab tech sector by untapping its human potential. Did you know that 52% of computer science graduates in Palestine are women? Follow us and visit our websiteto learn more.
- Roforco — Roforco runs a Roblox game accelerator that makes games successful by providing funding, resources and hands-on support. It's YCombinator for Roblox games, built by two YCombinator Alumni. Co-founders Artem and Brain have been building games together since they were 14 were developers on 12 top grossing titles, accounting for over 2.74billion plays/downloads.Prior to building the accelerator, Roforco was a game studio with a portfolio of games that reached benchmarks including 10 million monthly active users and 16,000 concurrent users. Roforco also worked with notable brands such as Unilever, for whom they made an branded game with over 50 million plays.In 2022, Roforco joined YCombinator's coveted startup accelerator and went on to secure a $1.5 million seed funding round from investors including Paul Graham, Dentsu Group, the prev. COO of Activision and the CEOs of Guilded and Jellysmack. Learn more about us at https://roforco.com/For press: tom@roforco.com Based and founded in San Francisco, CA
Mark Bamforth is the Operating Partner at Ampersand Capital Partners.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: United Kingdom, United States
Investor stats
- Total investments: 9
- Round size: Series A $9.2M–$19M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- PneumoWave — Empowering Intervention and Prevention for Opioid-Induced Respiratory Depression
- Talking Medicines — Data tech innovator Talking Medicines, based in Glasgow and London, uses advanced AI and ML to provide pharmaceutical companies with real-time data intelligence. The company uses a collection of AI, ML and NLP tech tools to capture and structure the voice of the patient from real world conversations and behaviours at home. Through mapping thepatient voice from social media and connected devices to regulated medicine information, the company is able to build data points to deliver trends and patterns of patient sentiment across medicines. This intelligence embraces regulatory compliance enabling marketing in pharmaceutical companies to measure patient confidence by medicine and in turn action the levers for share growth.
Michael Cope - Founder, CEO @ Cope Ventures
Show more...Investment focus
- Industry: Health Care, Apps, mHealth
- Stage:Seed, Angel, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Validic — Validic is the healthcare industry's premier technology platform for convenient, easy data access to a world of mobile health and in-home devices, fitness equipment, clinical sensors, activity wearables, smart bands, and wellness applications. Founded in 2010, Validic is headquartered in Durham, North Carolina.
- Insight Optics — Insight Optics, is an impact driven startup dedicated to connecting Primary Care Providers with local specialists for assisted diagnostics. We do the heavy lifting with machine learning and computer vision to ensure untrained individuals have captured the right content and that it is of a diagnosable quality prior to transmission. We have built oursolution to ensure that we can capture non-adherent patients where they already are by deskilling the process and improving accessibility for the most rural, impoverished, and marginalized populations.Business Overview: Insight Optics empowers primary care providers (PCPs) to record and refer preventative pre-screening videos to local specialists for assisted diagnostics. Our goal is to enable PCPs to efficiently detect early signs of preventable diseases before permanent damage is done. We accomplish this by providing PCPs a platform to connect and send patient data to local specialists. This allows both users to monetize otherwise unrealized referral incentives and provide better care.Problem: Over 154 million patients in the United States are recommended for an annual retinal exam, especially those with a history of diabetes or high blood pressure. Unfortunately, less than 50% of this population will receive their screening due to the difficulty of visiting a specialist, lack of education or available specialists. However, most of these patients do see PCPs annually. Solution: We’ve developed a telemedicine PaaS, enabling PCPs to record and refer retinal exams to local specialists for assisted review. PCPs create a new revenue stream through reimbursements and government incentives. Specialists find qualified leads and increase their screening capacity without the need for in-person appointments in a non-adherent population.Benefits: The OptoView system acts as a new revenue stream for both PCPs and specialists through reimbursement. The tool satisfies HEDIS requirements for PCPs and acts as a lead generation tool for specialists to find new patients. Annual reports determine whether managed care organizations receive reimbursements or penalties from state and federal agencies. Our application is designed to satisfy the requirements for annual diabetic eye screenings, increasing an organization’s compliance rates and ophthalmologists prioritize sick patients.
Chip Hance
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
Medical Device Angel investor funding at a glance
Stats across 570 deals from 671 investors.
Access all 671 angel investors in Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Angel Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 671 angel investors investing in Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!